| Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection (NCT03915470) | Destiny Pharma Plc | 2019-08-29 |
| Ceftriaxone as Home IV for Staph Infections (NCT04141787) | Vancouver Island Health Authority | 2019-07-11 |
| Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China (NCT03456544) | Peking University First Hospital | 2018-10-31 |
| Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections (NCT02782078) | Assistance Publique - Hôpitaux de Paris | 2017-03-06 |
| Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery (NCT02595112) | Centre Hospitalier Universitaire de Saint Etienne | 2016-02-04 |
| Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne (NCT02502474) | Centre Hospitalier Universitaire de Saint Etienne | 2015-02-02 |
| Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years (NCT02364596) | Pfizer | 2015-01-01 |
| Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years (NCT01643941) | Pfizer | 2012-08-01 |
| Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection (NCT01144000) | Andrej Trampuz | 2012-06-01 |
| Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections (NCT02640937) | BG Unfallklinik Murnau | 2011-11-01 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326) | Daniel Benjamin | 2011-11-01 |
| Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device Related Bone Infections (NCT02971657) | BG Unfallklinik Murnau | 2011-11-01 |
| Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne (NCT02557568) | Centre Hospitalier Universitaire de Saint Etienne | 2011-10-01 |
| Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine (NCT01447407) | NovaDigm Therapeutics, Inc. | 2011-09-01 |
| Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years (NCT01364571) | Pfizer | 2011-08-01 |
| Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida (NCT01273922) | NovaDigm Therapeutics, Inc. | 2011-01-01 |
| Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty (NCT01196169) | Mountain Home Research & Education Corporation | 2010-10-01 |
| An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults (NCT01018641) | Pfizer | 2010-01-01 |
| Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection (NCT00859677) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2009-03-01 |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (NCT00509847) | AM-Pharma | 2009-02-01 |
| What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? (NCT00736554) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-07-01 |
| Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections (NCT00779246) | Christiana Care Health Services | 2008-06-01 |
| Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections (NCT00427076) | Rabin Medical Center | 2007-06-01 |
| Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons (NCT00631566) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2007-05-01 |
| Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) (NCT00666276) | Pfizer | 2007-02-01 |
| Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection (NCT00419991) | CPL Associates | 2007-01-01 |
| Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) (NCT01324440) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant (NCT00518076) | University of Sao Paulo | 2006-09-01 |
| Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis (NCT00620984) | State University of New York - Upstate Medical University | 2006-08-01 |
| A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely (NCT00368498) | National Taiwan University Hospital | 2006-06-01 |
| Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty (NCT00423982) | Oslo University Hospital | 2006-04-01 |
| V710 First-In-Man (FIM) Study (V710-001) (NCT00303069) | Merck Sharp & Dohme LLC | 2005-11-01 |
| Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections (NCT00501150) | Imperial College London | 2005-09-01 |
| Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease (NCT00130260) | Nabi Biopharmaceuticals | 2005-08-01 |
| Preventing Staphylococcal (Staph) Infection (NCT00108160) | US Department of Veterans Affairs | 2005-04-01 |
| Evaluation of Consistency of StaphVAX Manufacturing Lots (NCT00211991) | Nabi Biopharmaceuticals | 2005-04-01 |
| StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery (NCT00211965) | Nabi Biopharmaceuticals | 2005-04-01 |
| Evaluation of Manufacturing Lot of StaphVAX (NCT00211900) | Nabi Biopharmaceuticals | 2005-03-01 |
| StaphVAX Immunogenicity in Orthopedic Implant Patients (NCT00211926) | Nabi Biopharmaceuticals | 2004-12-01 |
| StaphVAX in Cardiovascular Surgery Patients (NCT00211913) | Nabi Biopharmaceuticals | 2004-06-01 |
| Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants (NCT00113191) | Bristol-Myers Squibb | 2004-05-01 |
| Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis (NCT00071214) | Nabi Biopharmaceuticals | 2003-09-01 |
| Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates (NCT00066989) | Nabi Biopharmaceuticals | 2003-07-01 |
| Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections (NCT00156377) | University Hospital Muenster | 2002-11-01 |
| Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever (NCT00063089) | Nabi Biopharmaceuticals | 2002-09-01 |
| Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus (NCT00175370) | University of British Columbia | 2000-09-01 |
| Preoperative Nasal Swabs From Pediatric Patients (NCT00646919) | Hillel Yaffe Medical Center | |